[1] |
PERETZ A,ON A,KOIEFMAN H,et al.BACTEC FX system as a tool for culturing gastric biopsies and Helicobacter pylori diagnosis[J]. Eur J Clin Microbiol Infect Dis,2013,32(12):1541-1543.
|
[2] |
BLASER MJ.Helicobacter pylori:its role in disease[J]. Clin Infect Dis,1992, 15(3):386-391.
|
[3] |
ALAHDAB YO,KALAYCI C.Helicobacter pylori:management in 2013[J]. World J Gastroenterol,2014, 20(18):5302-5307.
|
[4] |
LIM SG,PARK RW,SHIN SJ,et al.The relationship between the failure to eradicate Helicobacter pylori and previous antibiotics use[J]. Dig Liver Dis,2016,48(4):385-390.
|
[5] |
中华医学会消化病学分会胃肠动力学组. 中国消化不良的诊治指南(2007,大连)[J]. 中华消化杂志,2007,27(12):832-834.
|
[6] |
中华医学会消化病学分会幽门螺杆菌学组,成虹,胡伏莲,等. 中国幽门螺杆菌耐药状况以及耐药对治疗的影响——全国多中心临床研究[J]. 胃肠病学,2007,12(9):525-530.
|
[7] |
WHITMIRE JM,MERRELL DS.Successful culture techniques for Helicobacter species:general culture techniques for Helicobacter pylori[J]. Methods Mol Biol,2012,921:17-27.
|
[8] |
LLANES R,FELICIANO O,GUZMN D,et al.Use of a single biopsy specimen for diagnosing Helicobacter pylori infection by culture and two different PCR methods:report from Cuba[J]. Trop Gastroenterol,2010,31(2):111-112.
|
[9] |
Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing[S]. M100-S23,CLSI,2013.
|
[10] |
MGRAUD F,LEHN N,LIND T,et al.Antimicrobial susceptibility testing of Helicobacter pylori in a large multicenter trial:the MACH 2 study[J]. Antimicrob Agents Chemother,1999,43(11):2747-2752.
|
[11] |
YU C,LI L,CHEN W,et al.Levofloxacin susceptibility testing for Helicobacter pylori in China:comparison of E-test and disk diffusion method[J]. Helicobacter,2011,16(2):119-123.
|
[12] |
高承霞,严祥,韩俭,等. E-test法检测幽门螺杆菌对3种抗生素的耐药性[J]. 国际消化病杂志,2013,33(1):61-63.
|
[13] |
WONG BC,LAM SK,WONG WM,et al.Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China:a randomized controlled trial[J]. JAMA,2004,291(2):187-194.
|
[14] |
THUNG I,ARAMIN H,VAVINSKAYA V,et al.Review article:the global emergence of Helicobacter pylori antibiotic resistance[J]. Aliment Pharmacol Ther,2016,43(4):514-533.
|
[15] |
MARSHALL BJ,WINDSOR HM.The relation of Helicobacter pylori to gastric adenocarcinoma and lymphoma:pathophysiology,epidemiology,screening,clinical presentation,treatment,and prevention[J]. Med Clin North Am,2005,89(2):313-344.
|
[16] |
项利娟,朱新建,黄德富,等. 幽门螺杆菌感染调查与耐药性分析[J]. 中华医院感染学杂志,2015,25(8): 1710-1711.
|
[17] |
O'CONNOR A,GISBERT JP,O'MORAIN C,et al. Treatment of Helicobacter pylori infection 2015[J]. Helicobacter,2015,20(Suppl 1):54-61.
|
[18] |
UYGUN A,KADAYIFCI A,SAFALI M,et al.The efficacy of bismuth containing quadruple therapy as a first-line treatment option for Helicobacter pylori[J]. J Dig Dis,2007,8(4):211-215.
|
[19] |
LIOU JM,BAIR MJ,CHEN CC,et al.Levofloxacin sequential therapy vs levofloxacin triple therapy in the second-line treatment of Helicobacter pylori:a randomized trial[J]. Am J Gastroenterol,2016,111(3):318-387.
|
[20] |
AGUDO S,PEREZ-PEREZ G,ALARCON T,et al.High prevalence of clarithromycin-resistant Helicobacter pylori strains and risk factors associated with resistance in Madrid,Spain[J]. J Clin Microbiol,2010,48(10):3703-3707.
|
[21] |
GARCIA M,RAYMOND J,GARNIER M,et al.Distribution of spontaneous gyrA mutations in 97 fluoroquinolone-resistant Helicobacter pylori isolates collected in France[J]. Antimicrobial Agents Chemother,2011,56(1):550-551.
|
[22] |
CHUNG JW,LEE GH,JEONG JY,et al.Resistance of Helicobacter pylori strains to antibiotics in Korea with a focus on fluoroquinolone resistance[J]. J Gastroenterol Hepatol,2012,27(3):493-497.
|
[23] |
黄一沁,张赣生,胡晓娜,等. 10d序贯治疗根除幽门螺杆菌的疗效评价[J].国际病理科学与临床杂志,2012,32(3):205-210.
|
[24] |
TANIH NF,NDIP LM,NDIP RN.Characterisation of the genes encoding resistance to metronidazole (rdxA and frxA) and clarithromycin (the 23S-rRNA genes) in South African isolates of Helicobacter pylori[J]. Ann Trop Med Parasitol,2011,105(3):251-259.
|
[25] |
张万岱,胡伏莲,萧树东,等. 中国自然人群幽门螺杆菌感染的流行病学调查[J]. 现代消化及介入诊疗,2010,15(5):265-270.
|
[26] |
National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing[S]. M100-S10,NCCLS,2000.
|
[27] |
GERRITS MM,VAN VLIET AH,KUIPERS EJ,et al.Helicobacter pylori and antimicrobial resistance:molecular mechanisms and clinical implications[J]. Lancet Infect Dis,2006,6(11):699-709.
|
[28] |
孔聪聪,刘改芳. 幽门螺杆菌对抗生素耐药的分子机制研究进展[J]. 临床荟萃,2014,29(4): 478-481.
|